These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8417204)
1. Pseudomonas exotoxin conjugated to monoclonal antibody MRK16 specifically kills multidrug resistant cells in cultured renal carcinomas and in MDR-transgenic mice. Mickisch GH; Pai LH; Siegsmund M; Campain J; Gottesman MM; Pastan I J Urol; 1993 Jan; 149(1):174-8. PubMed ID: 8417204 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice. Mickisch GH; Pai LH; Gottesman MM; Pastan I Cancer Res; 1992 Aug; 52(16):4427-32. PubMed ID: 1353705 [TBL] [Abstract][Full Text] [Related]
3. Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates. Roffler SR; Yu MH; Chen BM; Tung E; Yeh MY Cancer Res; 1991 Aug; 51(15):4001-7. PubMed ID: 1855216 [TBL] [Abstract][Full Text] [Related]
4. Human renal cell carcinoma cells are sensitive to the cytotoxic effect of a chimeric protein composed of human interleukin-4 and Pseudomonas exotoxin. Puri RK; Debinski W; Obiri N; Kreitman R; Pastan I Cell Immunol; 1994 Apr; 154(1):369-79. PubMed ID: 8131209 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer. Pai LH; Bookman MA; Ozols RF; Young RC; Smith JW; Longo DL; Gould B; Frankel A; McClay EF; Howell S J Clin Oncol; 1991 Dec; 9(12):2095-103. PubMed ID: 1960550 [TBL] [Abstract][Full Text] [Related]
6. Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon. Pearson JW; Hedrick E; Fogler WE; Bull RL; Ferris DK; Riggs CW; Wiltrout RH; Sivam G; Morgan AC; Groves E Cancer Res; 1990 Oct; 50(19):6379-88. PubMed ID: 2144790 [TBL] [Abstract][Full Text] [Related]
7. Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats. Engebraaten O; Sivam G; Juell S; Fodstad O Int J Cancer; 2000 Dec; 88(6):970-6. PubMed ID: 11093823 [TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells. FitzGerald DJ; Willingham MC; Cardarelli CO; Hamada H; Tsuruo T; Gottesman MM; Pastan I Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4288-92. PubMed ID: 3495806 [TBL] [Abstract][Full Text] [Related]
9. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model. Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147 [TBL] [Abstract][Full Text] [Related]
10. Selective elimination of breast cancer cells from human bone marrow using an antibody-Pseudomonas exotoxin A conjugate. Bjorn MJ; Manger R; Sivam G; Morgan AC; Torok-Storb B Cancer Res; 1990 Sep; 50(18):5992-6. PubMed ID: 2118424 [TBL] [Abstract][Full Text] [Related]
11. Pseudomonas exotoxin-based immunotoxins containing the antibody LL2 or LL2-Fab' induce regression of subcutaneous human B-cell lymphoma in mice. Kreitman RJ; Hansen HJ; Jones AL; FitzGerald DJ; Goldenberg DM; Pastan I Cancer Res; 1993 Feb; 53(4):819-25. PubMed ID: 8428363 [TBL] [Abstract][Full Text] [Related]
12. Anti-prostate immunotoxins: cytotoxicity of E4 antibody-Pseudomonas exotoxin constructs. Essand M; Pastan I Int J Cancer; 1998 Jul; 77(1):123-7. PubMed ID: 9639403 [TBL] [Abstract][Full Text] [Related]
13. Antibody-Pseudomonas exotoxin A conjugates cytotoxic to human breast cancer cells in vitro. Bjorn MJ; Groetsema G; Scalapino L Cancer Res; 1986 Jul; 46(7):3262-7. PubMed ID: 3011243 [TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin. Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3358-62. PubMed ID: 2014255 [TBL] [Abstract][Full Text] [Related]
15. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. Kreitman RJ; Bailon P; Chaudhary VK; FitzGerald DJ; Pastan I Blood; 1994 Jan; 83(2):426-34. PubMed ID: 8286741 [TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys. Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I Cancer Res; 1992 Jun; 52(11):3189-93. PubMed ID: 1591729 [TBL] [Abstract][Full Text] [Related]
17. A recombinant immunotoxin that is active on prostate cancer cells and that is composed of the Fv region of monoclonal antibody PR1 and a truncated form of Pseudomonas exotoxin. Brinkmann U; Gallo M; Brinkmann E; Kunwar S; Pastan I Proc Natl Acad Sci U S A; 1993 Jan; 90(2):547-51. PubMed ID: 8421689 [TBL] [Abstract][Full Text] [Related]
18. Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer. Zangemeister-Wittke U; Collinson AR; Frösch B; Waibel R; Schenker T; Stahel RA Br J Cancer; 1994 Jan; 69(1):32-9. PubMed ID: 7506925 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A. Rosada RS; Moreira AP; Frantz FG; Puri RK; Rahman A; Standiford TJ; Zárate-Bladés CR; Silva CL; Hogaboam CM PLoS One; 2010 Jan; 5(1):e8721. PubMed ID: 20090941 [TBL] [Abstract][Full Text] [Related]
20. Pseudomonas exotoxin and recombinant immunotoxins derived from it. Fitzgerald D; Pastan I Ann N Y Acad Sci; 1993 Jun; 685():740-5. PubMed ID: 8363279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]